0,880  0,002  Pneumotoxic
0,801  0,011  Caspase 9 stimulant
0,760  0,006  CYP1A2 substrate
0,757  0,004  Genotoxic
0,757  0,004  UGT1A6 substrate
0,751  0,002  GST P1-1 substrate
0,745  0,006  Sensitization
0,747  0,010  CYP2C9 substrate
0,736  0,004  Antimutagenic
0,736  0,025  Apoptosis agonist
0,712  0,004  Superoxide dismutase inhibitor
0,686  0,014  GST A substrate
0,684  0,022  Transcription factor NF kappa B inhibitor
0,670  0,012  Chemoprotective
0,663  0,017  TNF expression inhibitor
0,651  0,006  Free radical scavenger
0,640  0,010  CTGF expression inhibitor
0,656  0,026  Antineoplastic (breast cancer)
0,638  0,009  NOS3 expression inhibitor
0,640  0,014  Aldehyde oxidase inhibitor
0,635  0,010  CYP2D6 substrate
0,647  0,024  Antineoplastic (lung cancer)
0,627  0,009  Antioxidant
0,626  0,009  NOS2 expression inhibitor
0,626  0,012  5 Hydroxytryptamine release stimulant
0,620  0,012  Antineoplastic (cervical cancer)
0,608  0,005  Tubulin antagonist
0,607  0,006  UGT1A1 substrate
0,616  0,022  Antileukemic
0,586  0,011  Antineoplastic (non-small cell lung cancer)
0,588  0,014  Chemopreventive
0,581  0,007  FMO1 substrate
0,582  0,015  Antineoplastic (melanoma)
0,571  0,004  Glutathione S-transferase substrate
0,590  0,024  Antineoplastic (colorectal cancer)
0,561  0,005  UGT2B4 substrate
0,549  0,008  UGT1A4 substrate
0,548  0,010  Amyloid beta aggregation inhibitor
0,557  0,020  Vasodilator, peripheral
0,562  0,026  Antineoplastic (colon cancer)
0,546  0,015  Cardiovascular analeptic
0,524  0,004  Carcinogenic, group 2B
0,526  0,007  Monophenol monooxygenase inhibitor
0,545  0,034  CYP3A4 substrate
0,531  0,021  Carcinogenic
0,529  0,023  CYP2C19 substrate
0,532  0,027  Prostate cancer treatment
0,509  0,019  AR expression inhibitor
0,495  0,008  Radiosensitizer
0,494  0,008  Carcinogenic, group 3
0,498  0,015  Cardiodepressant
0,487  0,005  5 Hydroxytryptamine uptake stimulant
0,501  0,021  12-Lipoxygenase inhibitor
0,500  0,021  Mutagenic
0,486  0,013  UDP-glucuronosyltransferase substrate
0,494  0,021  UGT1A9 substrate
0,486  0,013  Antimitotic
0,476  0,007  Calcium channel activator
0,487  0,020  Antineoplastic (glioma)
0,483  0,023  Caspase 3 stimulant
0,474  0,017  Antineoplastic (glioblastoma multiforme)
0,485  0,029  Antineoplastic (ovarian cancer)
0,483  0,027  Ulceration
0,462  0,009  Melanin inhibitor
0,462  0,014  Skin irritative effect
0,453  0,009  Skin whitener
0,476  0,035  Teratogen
0,473  0,037  Cholesterol antagonist
0,449  0,014  Peroxidase inhibitor
0,460  0,026  Antineoplastic (brain cancer)
0,439  0,007  VCAM1 expression inhibitor
0,465  0,034  CYP2C19 inhibitor
0,473  0,047  15-Lipoxygenase inhibitor
0,429  0,007  UGT2B15 substrate
0,446  0,027  Lipoxygenase inhibitor
0,445  0,029  Antineoplastic (pancreatic cancer)
0,450  0,036  Embryotoxic
0,458  0,046  Histamine release inhibitor
0,430  0,018  Antihypertriglyceridemic
0,435  0,024  Antiprotozoal (Leishmania)
0,436  0,026  Vasodilator, coronary
0,411  0,004  Succinate dehydrogenase inhibitor
0,411  0,004  Beta tubulin antagonist
0,429  0,023  DNA damaging
0,443  0,037  Respiratory analeptic
0,425  0,023  Nitric oxide antagonist
0,416  0,018  Eye irritation, high
0,425  0,033  Radioprotector
0,401  0,010  Phospholipase C inhibitor
0,391  0,005  NADPH oxidase inhibitor
0,418  0,033  Apoptosis antagonist
0,412  0,027  Hypoxia-inducible factor 1 alpha inhibitor
0,396  0,012  UGT1A3 substrate
0,423  0,039  Antihypercholesterolemic
0,407  0,026  Tumour necrosis factor alpha release inhibitor
0,456  0,076  Antineoplastic (solid tumors)
0,396  0,019  FMO3 substrate
0,379  0,003  Phenylalanine 4-hydroxylase inhibitor
0,388  0,014  Antiseptic
0,399  0,027  Antipyretic
0,381  0,014  Antihypotensive
0,400  0,038  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,464  0,103  Antiinflammatory
0,398  0,039  Cardioprotectant
0,424  0,066  Antibacterial
0,369  0,011  Amylase inhibitor
0,375  0,017  GST M1-1 substrate
0,387  0,031  Proliferative diseases treatment
0,409  0,058  GABA C receptor rho-3 antagonist
0,369  0,021  Abortion inducer
0,385  0,038  Cytotoxic
0,376  0,029  Antineoplastic (renal cancer)
0,370  0,024  Antineoplastic enhancer
0,375  0,031  Antihypoxic
0,364  0,021  Growth hormone agonist
0,406  0,066  Antiprotozoal
0,347  0,009  Sulfotransferase substrate
0,352  0,015  Tyrosine 3 hydroxylase inhibitor
0,364  0,030  Antineoplastic (liver cancer)
0,347  0,014  DNA methyltransferase I inhibitor
0,380  0,048  ICAM1 expression inhibitor
0,364  0,032  Antineoplastic (osteosarcoma)
0,332  0,004  UGT2B10 substrate
0,329  0,007  SULT1A3 substrate
0,336  0,014  Lipid peroxidase inhibitor
0,391  0,070  Antipruritic, allergic
0,350  0,030  Sigma receptor agonist
0,352  0,033  Vasodilator
0,325  0,007  Aldehyde oxidase substrate
0,321  0,008  Cystathionine beta-synthase inhibitor
0,326  0,014  Tumour necrosis factor antagonist
0,353  0,042  CYP1A2 inhibitor
0,329  0,021  DNA methylase inhibitor
0,320  0,012  Interleukin 6 antagonist
0,341  0,036  Transcription factor STAT3 inhibitor
0,317  0,014  Amyloid beta precursor protein antagonist
0,353  0,050  Analeptic
0,332  0,031  Cyclic AMP phosphodiesterase inhibitor
0,338  0,038  Pyruvate kinase inhibitor
0,363  0,066  Angiogenesis inhibitor
0,312  0,015  CYP2B6 inhibitor
0,363  0,066  Antiprotozoal (Plasmodium)
0,306  0,010  Carcinogenic, group 1
0,304  0,012  M18 aspartyl aminopeptidase inhibitor
0,313  0,027  P-glycoprotein inhibitor
0,311  0,024  UGT2B7 substrate
0,329  0,045  Antineoplastic (endocrine cancer)
0,302  0,018  NOS3 expression enhancer
0,293  0,011  UGT2B9 substrate
0,322  0,043  Flavin-containing monooxygenase substrate
0,300  0,022  Antineoplastic (squamous cell carcinoma)
0,280  0,004  Vanilloid 1 agonist
0,280  0,005  Toll-Like receptor 2 antagonist
0,391  0,119  Alpha-glucosidase inhibitor
0,301  0,033  Anesthetic general
0,316  0,047  Transcription factor STAT inhibitor
0,278  0,013  5-Lipoxygenase inhibitor
0,282  0,017  MAO A inhibitor
0,284  0,019  Protein kinase stimulant
0,296  0,031  Hepatoprotectant
0,277  0,013  Antifungal enhancer
0,271  0,010  Age-related macular degeneration treatment
0,294  0,035  ErbB-1 antagonist
0,272  0,013  LDLR expression enhancer
0,279  0,022  Antineoplastic (gastric cancer)
0,263  0,006  Estrogen receptor beta antagonist
0,259  0,004  Adenylate cyclase stimulant
0,263  0,008  Estrogen antagonist
0,325  0,070  Antifungal
0,291  0,036  5 Hydroxytryptamine 1E antagonist
0,263  0,008  SULT1A1 substrate
0,277  0,023  Antihelmintic (Nematodes)
0,277  0,023  MAO inhibitor
0,277  0,025  Antineoplastic (carcinoma)
0,275  0,024  Interferon gamma antagonist
0,256  0,005  Alpha tubulin antagonist
0,260  0,009  Breast cancer-resistant protein inhibitor
0,277  0,027  Antipruritic, non-allergic
0,271  0,021  Nitric-oxide synthase stimulant
0,301  0,052  Hypoglycemic
0,281  0,033  Non-steroidal antiinflammatory agent
0,251  0,005  Vanilloid agonist
0,301  0,058  Insulysin inhibitor
0,288  0,047  Antineoplastic (sarcoma)
0,304  0,069  Spasmolytic
0,241  0,008  Porphobilinogen synthase inhibitor
0,268  0,035  Dual specificity phosphatase 3 inhibitor
0,298  0,067  Antineoplastic (multiple myeloma)
0,271  0,041  Sedative
0,240  0,010  Cyclooxygenase 3 inhibitor
0,247  0,018  Cholesterol synthesis inhibitor
0,235  0,007  HIV-1 integrase (3'-Processing) inhibitor
0,249  0,021  Cyclooxygenase 1 inhibitor
0,260  0,033  Neurotrophic factor enhancer
0,231  0,006  Keratolytic
0,232  0,008  Photosensitizer
0,282  0,058  Antiamyloidogenic
0,344  0,121  5 Hydroxytryptamine release inhibitor
0,235  0,013  Microtubule formation inhibitor
0,276  0,058  Cytostatic
0,233  0,015  Expectorant
0,303  0,086  Antithrombotic
0,254  0,041  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,220  0,008  HIV-1 integrase (Strand Transfer) inhibitor
0,231  0,023  VEGF expression inhibitor
0,225  0,017  Ferrochelatase inhibitor
0,211  0,004  UGT2B11 substrate
0,244  0,038  Mcl-1 antagonist
0,268  0,062  Angiogenesis stimulant
0,212  0,010  Gastritis treatment
0,259  0,057  Antiparasitic
0,222  0,021  Chelator
0,215  0,015  CF transmembrane conductance regulator agonist
0,212  0,014  UGT2B1 substrate
0,259  0,063  Antineoplastic (lymphoma)
0,208  0,013  Carbonic anhydrase XIII inhibitor
0,239  0,043  Muscle relaxant
0,208  0,015  Carbonic anhydrase III inhibitor
0,199  0,006  Heat shock protein 70 antagonist
0,251  0,059  Antiulcerative
0,303  0,113  Immunosuppressant
0,232  0,042  Dual specificity phosphatase inhibitor
0,239  0,049  Antihelmintic
0,285  0,096  Antineoplastic (small cell lung cancer)
0,207  0,017  Carbonic anhydrase XV inhibitor
0,202  0,013  Carbonic anhydrase VI inhibitor
0,215  0,027  ATPase inhibitor
0,205  0,018  Xanthine oxidase inhibitor
0,242  0,056  Peptidyltransferase inhibitor
0,258  0,073  Interleukin agonist
0,198  0,014  Mucolytic
0,211  0,027  Antirickettsial
0,226  0,043  Antiviral (Hepatitis)
0,213  0,031  Antineoplastic (bone cancer)
0,211  0,031  Uterine stimulant
0,233  0,054  Antiviral (Influenza)
0,197  0,018  Choleretic
0,184  0,005  Estrogen receptor beta agonist
0,191  0,013  TRPA1 agonist
0,209  0,031  Neurotensin receptor agonist
0,208  0,030  Alkaline phosphatase inhibitor
0,204  0,027  GABA C receptor rho-2 antagonist
0,236  0,059  RNA-directed DNA polymerase inhibitor
0,181  0,006  Antifungal (Pneumocystis)
0,326  0,151  DNA polymerase beta inhibitor
0,200  0,025  Adenylate cyclase inhibitor
0,203  0,030  Arachidonic acid antagonist
0,208  0,037  Antiviral (Hepatitis C)
0,201  0,031  Catenin beta inhibitor
0,183  0,013  Carcinogenic, group 2A
0,291  0,123  CYP2C9 inhibitor
0,181  0,015  Antiviral (Influenza B)
0,205  0,039  Skeletal muscle relaxant
0,239  0,074  Antineoplastic (lymphocytic leukemia)
0,190  0,025  Interleukin 4 antagonist
0,189  0,025  Antibacterial (Helicobacter pylori)
0,171  0,006  Thioredoxin reductase inhibitor
0,218  0,056  Insulin sensitizer
0,179  0,018  Aldehyde dehydrogenase substrate
0,170  0,010  Estrogen agonist
0,206  0,045  Heat shock protein 90 alpha antagonist
0,177  0,016  Beta glucuronidase inhibitor
0,203  0,044  Hair growth stimulant
0,313  0,155  DNA directed DNA polymerase inhibitor
0,167  0,010  Estrogen receptor alpha antagonist
0,191  0,034  Antianemic
0,169  0,013  Toll-Like receptor 4 antagonist
0,166  0,012  Macrophage migration inhibitory factor inhibitor
0,196  0,041  Antidote
0,179  0,025  Interleukin 1b antagonist
0,172  0,019  Antineoplastic (uterine cancer)
0,195  0,044  Contraceptive
0,174  0,024  Bronchodilator
0,191  0,040  Antidiarrheal
0,163  0,015  DOPA decarboxylase inhibitor
0,183  0,037  Cocaine dependence treatment
0,196  0,049  Acaricide
0,165  0,020  HIV-1 integrase (Overall Integration) inhibitor
0,160  0,016  NAD(P)H dehydrogenase (quinone) inhibitor
0,156  0,012  Glutamate decarboxylase inhibitor
0,174  0,030  MAO B inhibitor
0,184  0,040  Mannose-6-phosphate isomerase inhibitor
0,174  0,030  Antiprotozoal (Amoeba)
0,205  0,062  Histone acetyltransferase inhibitor
0,165  0,023  Papain-like protease (SARS coronavirus) inhibitor
0,189  0,048  Phobic disorders treatment
0,157  0,017  Electron transport complex I inhibitor
0,218  0,080  Antiviral (West Nile virus)
0,141  0,004  Glucose-6-phosphate translocase inhibitor
0,158  0,022  Dementia treatment
0,157  0,022  Multidrug resistance-associated protein 1 inhibitor
0,142  0,007  Granulocyte macrophage colony stimulating factor agonist
0,170  0,037  Alkylator
0,186  0,054  Cytidine deaminase inhibitor
0,145  0,013  Ornithine decarboxylase inhibitor
0,183  0,052  Antiviral (Influenza A)
0,149  0,020  Histidine decarboxylase inhibitor
0,152  0,022  Vascular dementia treatment
0,183  0,054  Protein-tyrosine phosphatase inhibitor
0,133  0,005  Potassium channel Kv1.3 blocker
0,226  0,098  Antiprotozoal (Trypanosoma)
0,140  0,012  Antifungal (Aspergillus)
0,171  0,043  Acetylcholinesterase inhibitor
0,138  0,011  Biliverdin reductase inhibitor
0,157  0,030  Alcohol dehydrogenase substrate
0,175  0,049  Anesthetic
0,147  0,023  Antispirochetal
0,180  0,057  Antiviral (Herpes)
0,193  0,070  Sepsis treatment
0,134  0,011  GABA aminotransferase inhibitor
0,285  0,163  Transcription factor inhibitor
0,175  0,054  Cyclooxygenase inhibitor
0,128  0,007  Endocannabinoid uptake inhibitor
0,126  0,005  Estrogen-related receptor alpha antagonist
0,139  0,019  SULT1E1 substrate
0,158  0,040  Antihemorrhagic
0,208  0,091  Antiglaucomic
0,128  0,011  SULT1A2 substrate
0,163  0,048  Alpha-N-acetylglucosaminidase inhibitor
0,153  0,037  Ca2+-transporting ATPase inhibitor
0,192  0,078  I kappa B kinase epsilon inhibitor
0,165  0,052  Cell wall synthesis inhibitor
0,198  0,085  Interleukin antagonist
0,156  0,044  Aldehyde dehydrogenase inhibitor
0,130  0,018  Phosphodiesterase 6D inhibitor
0,168  0,057  Heat shock protein 90 antagonist
0,186  0,078  Platelet adhesion inhibitor
0,136  0,029  Prolactin inhibitor
0,125  0,019  Dopamine D1 antagonist
0,141  0,034  Antihelmintic (Fasciola)
0,191  0,085  Psychostimulant
0,126  0,020  Glutathione S-transferase inhibitor
0,147  0,042  Coagulant
0,205  0,100  Aryl hydrocarbon receptor agonist
0,130  0,025  Thioredoxin inhibitor
0,133  0,028  Anabolic
0,131  0,027  Topoisomerase II alpha inhibitor
0,119  0,015  HIV-1 integrase inhibitor
0,107  0,005  Transcription factor RelA inhibitor
0,148  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,106  0,004  Adenylate cyclase 1 inhibitor
0,105  0,005  Postcoital contraceptive
0,154  0,054  Interleukin 1 antagonist
0,113  0,013  Estrogen-related receptor beta agonist
0,152  0,052  Antieczematic
0,113  0,013  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,141  0,042  Contraceptive female
0,132  0,033  Creatine kinase inhibitor
0,131  0,034  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,126  0,030  Androgen antagonist
0,106  0,010  Antimycoplasmal
0,100  0,005  Factor III inhibitor
0,209  0,115  Immunostimulant
0,237  0,143  Sodium/bile acid cotransporter inhibitor
0,115  0,023  ATPase (Vacuolar H+) inhibitor
0,126  0,033  Protein kinase C delta inhibitor
0,120  0,028  Antidote, mercury
0,144  0,052  DNA polymerase I inhibitor
0,132  0,042  Alpha 2c adrenoreceptor antagonist
0,129  0,040  Mediator release inhibitor
0,136  0,047  Topoisomerase I inhibitor
0,091  0,003  Estrogen-related receptor beta antagonist
0,126  0,040  Acetylcholine release stimulant
0,092  0,007  Squalene epoxidase inhibitor
0,109  0,024  Carbonic anhydrase V inhibitor
0,221  0,136  Bone diseases treatment
0,151  0,068  Movement disorders treatment
0,087  0,005  Catechol O-methyltransferase inhibitor
0,087  0,006  Ryanodine receptor antagonist
0,099  0,017  GABA B receptor agonist
0,104  0,023  Carbonic anhydrase VA inhibitor
0,178  0,097  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,105  0,024  D-Ala-D-Ala ligase inhibitor
0,115  0,035  Triose-phosphate isomerase inhibitor
0,130  0,051  Alpha 2b adrenoreceptor antagonist
0,138  0,059  Antihelmintic (Trematoda)
0,185  0,108  Antiviral (HIV)
0,106  0,029  Myeloperoxidase inhibitor
0,085  0,008  Vanilloid 2 antagonist
0,082  0,005  Dopamine beta hydroxylase inhibitor
0,140  0,063  Toll-Like receptor antagonist
0,109  0,032  Alpha 2a adrenoreceptor antagonist
0,135  0,059  Epidermal growth factor receptor kinase inhibitor
0,087  0,010  Estrogen receptor alpha agonist
0,141  0,066  Antiacne
0,084  0,009  Anesthetic inhalation
0,126  0,052  Shock treatment
0,200  0,127  Antituberculosic
0,116  0,044  GABA C receptor rho-1 antagonist
0,119  0,047  Antiprotozoal (Toxoplasma)
0,130  0,060  Topoisomerase II inhibitor
0,115  0,045  Sphingomyelinase inhibitor
0,083  0,013  Estradiol 17 beta-dehydrogenase inhibitor
0,107  0,037  NADH dehydrogenase inhibitor
0,110  0,041  Alpha 2 adrenoreceptor antagonist
0,087  0,018  Antiviral (Parainfluenza)
0,121  0,052  GABA C receptor antagonist
0,135  0,066  Cyclooxygenase 2 inhibitor
0,089  0,020  Xanthine dehydrogenase inhibitor
0,197  0,128  DNA synthesis inhibitor
0,200  0,133  Streptokinase A inhibitor
0,075  0,007  Dopamine D5 agonist
0,073  0,008  Inosine monophosphate dehydrogenase inhibitor
0,108  0,043  Antineoplastic antibiotic
0,094  0,029  Narcotic antagonist
0,107  0,042  ABCA1 expression enhancer
0,084  0,021  Exportin-1 inhibitor
0,091  0,027  Glycine receptor agonist
0,097  0,034  Na+ K+ transporting ATPase inhibitor
0,100  0,037  Inducible nitric-oxide synthase inhibitor
0,084  0,021  Postmenopausal disorders treatment
0,150  0,088  Prostate disorders treatment
0,134  0,072  CNS active muscle relaxant
0,087  0,025  Aromatase inhibitor
0,096  0,035  Nicotinic alpha4beta2 receptor antagonist
0,113  0,052  Urease inhibitor
0,078  0,017  Calcium channel P-type blocker
0,077  0,017  Heme oxygenase stimulant
0,092  0,033  CDC25A inhibitor
0,124  0,064  Anesthetic local
0,111  0,052  Adenylate kinase inhibitor
0,075  0,018  Carbonic anhydrase XIV inhibitor
0,081  0,025  Purinergic P2X1 antagonist
0,078  0,023  Carbonic anhydrase VB inhibitor
0,110  0,055  GST T1-1 substrate
0,107  0,053  UDP-glucose 4-epimerase inhibitor
0,090  0,036  Phosphofructokinase-1 inhibitor
0,083  0,030  Anticholelithogenic
0,100  0,048  Calcium antagonist
0,079  0,026  SULT2A1 substrate
0,060  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,077  0,025  Androgen agonist
0,097  0,045  Arylamine N-Acetyltransferase substrate
0,085  0,034  MAP kinase kinase 7 inhibitor
0,100  0,049  Bile acid receptor antagonist
0,055  0,005  Vanilloid 3 antagonist
0,110  0,060  Antiviral (SARS coronavirus)
0,110  0,060  Antiviral (Coronavirus)
0,117  0,068  Proteasome inhibitor
0,057  0,009  Kainate receptor agonist
0,068  0,021  Leukotriene B4 antagonist
0,191  0,145  Antineoplastic (bladder cancer)
0,126  0,081  Sphingosine 1-phosphate receptor 2 antagonist
0,106  0,061  GABA C receptor agonist
0,200  0,156  Prostaglandin dehydrogenase inhibitor
0,081  0,039  Antitreponemal
0,065  0,022  Pregnane X receptor antagonist
0,081  0,039  Phosphodiesterase VI inhibitor
0,071  0,028  Alcohol oxidase inhibitor
0,072  0,030  Beta 3 adrenoreceptor antagonist
0,058  0,018  Fructose-1,6-bisphosphatase inhibitor
0,063  0,024  Dihydroorotate oxidase inhibitor
0,130  0,091  Antiprotozoal (Coccidial)
0,052  0,013  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,090  0,053  Phosphodiesterase IV inhibitor
0,106  0,068  Protein kinase C gamma inhibitor
0,079  0,041  Calcium channel L-type blocker
0,072  0,035  Beta adrenoreceptor antagonist
0,072  0,034  MDM2 inhibitor
0,074  0,037  Leukotriene antagonist
0,070  0,033  Prostaglandin EP2 antagonist
0,134  0,098  Hexokinase inhibitor
0,041  0,005  Inosine monophosphate dehydrogenase 2 inhibitor
0,089  0,054  Epidermal growth factor antagonist
0,081  0,046  Antibiotic
0,061  0,027  Lysine-specific demethylase 1A inhibitor
0,051  0,017  Retinoid X receptor agonist
0,051  0,018  Liver X receptor alpha agonist
0,192  0,159  Antimycobacterial
0,041  0,008  Sodium/glucose cotransporter 2 inhibitor
0,070  0,038  Aryl hydrocarbon receptor antagonist
0,091  0,060  Polo-like kinase-1 inhibitor
0,100  0,070  HDL-cholesterol increasing
0,060  0,030  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,069  0,039  Hyperparathyroidism treatment
0,047  0,018  Heme oxygenase inhibitor
0,086  0,057  Transcription factor NF kappa B stimulant
0,090  0,062  Paget's disease treatment
0,062  0,034  Beta 1 adrenoreceptor antagonist
0,064  0,037  Alpha 2 adrenoreceptor agonist
0,044  0,017  Vesicle monoamine transporter inhibitor
0,075  0,048  Metalloproteinase-9 inhibitor
0,041  0,014  Tubulin agonist
0,064  0,038  Antidote, heavy metal
0,052  0,026  Carbonic anhydrase VII inhibitor
0,040  0,014  Nucleoside transporters inhibitor
0,129  0,103  Pregnane X receptor agonist
0,142  0,116  3C-like protease (Human coronavirus) inhibitor
0,034  0,009  CYP24 inhibitor
0,106  0,082  Caspase 3 inhibitor
0,027  0,004  Antibiotic Anthracycline-like
0,058  0,035  Leukotriene C antagonist
0,055  0,033  Heparanase inhibitor
0,039  0,017  Melatonin 2 agonist
0,039  0,017  Sodium-dependent vitamin C transporter 2 inhibitor
0,073  0,051  Histone deacetylase SIRT1 stimulant
0,073  0,051  Histone deacetylase stimulant
0,042  0,020  Glutamate (mGluR8) agonist
0,037  0,016  HCV polyprotein inhibitor
0,111  0,091  Antihyperlipoproteinemic
0,068  0,047  Glutamate (mGluR7) antagonist
0,090  0,070  Butyrylcholinesterase inhibitor
0,051  0,031  HCV NS3/NS4A protease inhibitor
0,077  0,058  Antidote, organophosphates
0,030  0,011  Sodium/glucose cotransporter 1 inhibitor
0,030  0,011  Sodium/glucose cotransporter inhibitor
0,045  0,026  Guanylate cyclase inhibitor
0,057  0,038  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,027  0,010  Fructose-1,6-bisphosphatase 1 inhibitor
0,038  0,021  Phosphoglycerate kinase inhibitor
0,071  0,055  Glutamate dehydrogenase inhibitor
0,027  0,011  Dopamine D1 agonist
0,028  0,013  Vanilloid 2 agonist
0,126  0,111  Antifungal (Cryptococcus)
0,102  0,087  Beta amyloid protein antagonist
0,194  0,180  CYP3A4 inhibitor
0,103  0,089  Antineoplastic antimetabolite
0,091  0,077  Antifungal (Candida)
0,069  0,055  Catalase inhibitor
0,034  0,020  GABA transporter 3 inhibitor
0,050  0,036  Beta 2 adrenoreceptor antagonist
0,062  0,049  Neuraminidase (influenza) inhibitor
0,030  0,018  Uridine phosphorylase inhibitor
0,059  0,048  5 Hydroxytryptamine 2A agonist
0,222  0,211  Antiparkinsonian
0,184  0,173  Hepatic disorders treatment
0,020  0,009  Antibiotic Trimethoprim-like
0,102  0,091  Interleukin 8 antagonist
0,082  0,072  Tocolytic
0,053  0,043  Sphingosine kinase 2 inhibitor
0,034  0,025  Adenosine uptake inhibitor
0,089  0,079  Chronic obstructive bronchitis treatment
0,035  0,025  Progesterone antagonist
0,032  0,023  Glutamate (mGluR3) agonist
0,063  0,054  Potassium channel (ATP-sensitive) blocker
0,060  0,051  CDC25B inhibitor
0,031  0,023  ATP citrate lysase inhibitor
0,047  0,038  Topoisomerase II beta inhibitor
0,034  0,025  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,051  0,042  Maillard reaction inhibitor
0,046  0,037  Glucose-6-phosphate isomerase inhibitor
0,023  0,015  Prostaglandin F2 alpha agonist
0,033  0,025  Melatonin receptor 1A agonist
0,108  0,100  Sphingosine 1-phosphate receptor 4 antagonist
0,048  0,040  Prolyl endopeptidase inhibitor
0,028  0,020  Estrogen-related receptor gamma antagonist
0,072  0,065  Acetylcholine nicotinic antagonist
0,026  0,018  Thyroid hormone agonist
0,123  0,116  Raynaud's phenomenon treatment
0,052  0,044  Cyclin B2 inhibitor
0,189  0,182  Thioredoxin glutathione reductase inhibitor
0,056  0,049  Neuraminidase inhibitor
0,113  0,107  Nav1.6 sodium channel blocker
0,047  0,041  Lysophosphatidic acid 3 receptor antagonist
0,147  0,141  Antiparkinsonian, rigidity relieving
0,023  0,017  ICAM 1 antagonist
0,084  0,078  Glutamate release inhibitor
0,022  0,016  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,030  0,024  Cholesterol ester transfer protein antagonist
0,081  0,076  Actinic keratosis treatment
0,108  0,103  DNA repair enzyme inhibitor
0,028  0,024  Lysophosphatidic acid 2 receptor antagonist
0,083  0,079  Protein kinase C zeta inhibitor
0,058  0,055  Fibroblast growth factor 2 antagonist
0,116  0,113  Cholinergic
0,028  0,025  Squalene synthetase inhibitor
0,041  0,038  Dihydrofolate reductase inhibitor
0,056  0,053  Transcription factor AP-1 inhibitor
0,056  0,054  Purinergic P2X2 antagonist
0,057  0,055  Dopamine agonist
0,024  0,022  Complement factor 1s inhibitor
0,035  0,034  Dihydropteroate synthase inhibitor
0,074  0,074  Antineoplastic alkaloid
0,005  0,005  Insulin like growth factor 3 antagonist
0,115  0,115  Farnesoid X receptor antagonist

